These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3038392

  • 1. Comparison of chronic inhibition of renin and converting enzyme in the marmoset.
    Wood JM, Jobber RA, Baum HP, Hofbauer KG.
    Clin Exp Hypertens A; 1987; 9(2-3):337-43. PubMed ID: 3038392
    [Abstract] [Full Text] [Related]

  • 2. Biochemical effects of prolonged renin inhibition in marmosets.
    Wood JM, Jobber RA, Baum HP, de Gasparo M, Nussberger J.
    J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
    [Abstract] [Full Text] [Related]

  • 3. Effects of a specific and long-acting renin inhibitor in the marmoset.
    Wood JM, Gulati N, Forgiarini P, Fuhrer W, Hofbauer KG.
    Hypertension; 1985 Aug; 7(5):797-803. PubMed ID: 3928488
    [Abstract] [Full Text] [Related]

  • 4. Comparison of different drug interference with the renin-angiotensin system.
    Hofbauer KG, Fuhrer W, Heusser C, Wood JM.
    J Cardiovasc Pharmacol; 1985 Aug; 7 Suppl 4():S62-8. PubMed ID: 2412016
    [Abstract] [Full Text] [Related]

  • 5. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets.
    Wood JM, Baum HP, Jobber RA, Neisius D.
    J Cardiovasc Pharmacol; 1987 Aug; 10 Suppl 7():S96-8. PubMed ID: 2485073
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of renin-like activity in marmoset tissues by the renin inhibitor CGP 29 287.
    Wood JM, Baum HP, Carleton J, Dzau VJ.
    J Hypertens Suppl; 1987 Jul; 5(2):S67-9. PubMed ID: 3116182
    [Abstract] [Full Text] [Related]

  • 7. Haemodynamic effects of acute and chronic renin inhibition in marmosets.
    Wood JM, Baum HP, Forgiarini P, Gulati N, Jobber RA, Neisius D, Hofbauer KG.
    J Hypertens Suppl; 1989 Apr; 7(2):S37-42. PubMed ID: 2547039
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma renin during renin inhibition. Studies with a novel immunoassay.
    Hofbauer KG, Wood JM, Gulati N, Heusser C, Ménard J.
    Hypertension; 1985 Apr; 7(3 Pt 2):I61-5. PubMed ID: 2987126
    [Abstract] [Full Text] [Related]

  • 9. Renal vasodilatation after inhibition of renin or converting enzyme in marmoset.
    Neisius D, Wood JM, Hofbauer KG.
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H897-902. PubMed ID: 3022608
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of renin in the primate Callithrix jacchus (common marmoset).
    Hofbauer KG, Ménard J, Michel JB, Wood JM.
    Clin Exp Hypertens A; 1983 Nov; 5(7-8):1237-47. PubMed ID: 6196144
    [Abstract] [Full Text] [Related]

  • 11. Expression of components of the RAS during prolonged blockade at different levels in primates.
    Samani NJ, Cumin F, Kelly M, Wood JM.
    Am J Physiol; 1994 Oct; 267(4 Pt 1):E612-9. PubMed ID: 7943312
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction.
    Neisius D, Wood JM.
    J Hypertens; 1987 Dec; 5(6):721-5. PubMed ID: 2828470
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM, Mah SC, Baum HP, de Gasparo M, Cumin F, Rüeger H, Nussberger J.
    J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
    [Abstract] [Full Text] [Related]

  • 14. Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
    Waeber G, Burnier M, Porchet M, Nussberger J, Waeber B, Brunner HR.
    Eur J Clin Pharmacol; 1989 May; 36(6):587-91. PubMed ID: 2550244
    [Abstract] [Full Text] [Related]

  • 15. Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.
    Waeber G, Fasanella d'Amore T, Nussberger J, Waeber B, Brunner HR.
    Eur J Clin Pharmacol; 1987 May; 31(6):643-6. PubMed ID: 3030765
    [Abstract] [Full Text] [Related]

  • 16. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 17. Ro 42-5892 is a potent orally active renin inhibitor in primates.
    Fischli W, Clozel JP, el Amrani K, Wostl W, Neidhart W, Stadler H, Branca Q.
    Hypertension; 1991 Jul 15; 18(1):22-31. PubMed ID: 1830563
    [Abstract] [Full Text] [Related]

  • 18. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
    Wood JM, Schnell CR, Cumin F, Menard J, Webb RL.
    J Hypertens; 2005 Feb 15; 23(2):417-26. PubMed ID: 15662231
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies against human renin. Blood pressure effects in the marmoset.
    Wood JM, Heusser C, Gulati N, Forgiarini P, Hofbauer KG.
    Hypertension; 1986 Jul 15; 8(7):600-5. PubMed ID: 3013776
    [Abstract] [Full Text] [Related]

  • 20. Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A.
    Nussberger J, de Gasparo M, Juillerat L, Guyenne TT, Mooser V, Waeber B, Brunner HR.
    Clin Exp Hypertens A; 1987 Jul 15; 9(8-9):1353-66. PubMed ID: 2820626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.